TCL Archive President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants February 1, 1980
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies May 22, 2009
TCL Archive St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program. November 12, 2004